Transarterial chemoembolization of advanced hepatocellular carcinoma: CT parameters for evaluating the response to therapy;Multisequentielle arterielle chemoembolisation fortgeschrittener hepatozellularer karzinome: Computertomographische verlaufsparameter zur beurteilung des ansprechens auf die therapie

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 172, Issue 1, 2000, Pages 43-50

  Vogl, Th J ^a   Schroeder, H ^a   Trapp, M ^a   Straub, R ^a   Schuster, A ^a   Schuster, M ^a   Mack, M ^a   Souchon, F ^a   Neuhaus, P ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Computed tomography (CT); Hepatocellular carcinoma; Transarterial chemoembolization (TACE)

Indexed keywords

IODINATED POPPYSEED OIL; CISPLATIN; DOXORUBICIN;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CANCER REGRESSION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG RETENTION; HUMAN; LIVER CELL CARCINOMA; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; AGED; CHEMOEMBOLIZATION; FEMALE; FOLLOW UP; INTRAARTERIAL DRUG ADMINISTRATION; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; RADIOGRAPHY; SURVIVAL RATE; TUMOR RECURRENCE; VASCULARIZATION;

AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRA-ARTERIAL; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0033622012     PISSN: 09366652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bruix J, Castells A, Motanya X, Calvet X, Bru C, Ayuso C, Jover L, Garcia R, Vilana R, Broix L. Phase II study of transarterial embolization in European patients with hepatocellular carcinoma: need for controlled trials. Hepatology 1994; 20: 643-650
2. Choi I, Kim HC, Han JK, Park JH, Kim YI, Kim YI, Kim ST, Lee HS, Kim CY, Han MC. Therapeutic effect of transcatheter oily chemoembolization therapy for encapsulated nodular hepatocellular carcinoma: CT and pathologic findings. Radiology 1992; 182: 709-713
3. Huppert PE, Geißler F, Duda SH, Lauchart W, Dette S, Dietz K, Brambs HJ, Claussen CD. Chemoembolisation des hepatozellulären Karzinoms: Computertomographische Befunde und klinische Resultate bei prospektiv repetitiver Therapie. Fortschr Röntgenstr 1994; 160: 425-432
4. Ikeda K, Kumada H, Saitoh S, Arase Y, Chayama K. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model. Cancer 1991; 68: 2150-2154
5. Nakamura H, Tanaka T, Hori S, Yoshioka H, Kuroda C, Okamura J, Sakurai M. Transcatheter embolisation of hepatocellular carcinoma: Assessment of efficacy in cases of resection following embolisation. Radiology 1983; 147: 401-405
6. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki M, Hasegawa H, Nakahima Y, Ohnishi K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment, study of 850 patients. Cancer 1985; 56: 918-928
7. Colella G, Bottelli R, De Carlis L, Sansalone CV, Rondinara GF, Alberti A, Belli LS, Gelosa F, Iamoni GM, Rampoldi A, De Gasperi A, Corti A, Mazza E, Aseni P, Meroni A, Slim AO, Finzi M, Di Benedetto F, Manochehri F, Follini ML, Ideo G, Forti D. Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization. Radiol Med 1998; 95: 362-368
8. Lencioni R, Paolicchi A, Moretti M, Pinto F, Armillotta N, Di Giulio M, Cicorelli A, Donati F, Cioni D, Bartolozzi C. Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long-term survival rate. Eur Radiol 1998; 8: 439-444
9. Vogl TJ, Muller PK, Mack MG, Straub R, Engelmann K, Neuhaus P. Liver metastases: interventional therapeutic techniques and results, state of the art. Eur Radiol 1999; 9: 675-684
10. Palma LD. Diagnostic imaging and interventional therapy of hepatocellular carcinoma. Br J Radiol 1998; 71: 808-818
11. Shah SR, Riordan SM, Karani J, Williams R. Tumour ablation and hepatic decompensation rates in multi-agent chemoembolization of hepatocellular carcinoma. QJM 1998; 91: 821-828
12. Gattoni F, Cornalba G, Brambilla G, Dova S, Pompili G, Rampoldi A, Damiani G, Carnevali G, Uslenghi CM. Survival of 184 patients with hepatocellular carcinoma in cirrhotic liver treated with chemoembolization. A multicenter study. Radiol Med 1998; 95: 362-368
13. Yamada T, Makita F, Takehara K, Saitou S, Satou S, Endou K, Shimoda R, Matsuzaki Y, Yuasa K, Takagi H, Yamada S, Mori M. Evaluation of the therapeutic effect of TAE on primary liver cancer. Cancer Chemother Pharmacol 1996; 33 (Suppl): S55-S59
14. Di Carlo V, Ferrari G, Castoldi R, De Nardi P, Bergamo C, Taccagni G, Salvioni M, Angeli E, Venturini M, Del Maschio A. Pre-operative chemoembolization of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 1998; 45: 1950-1954
15. Fan J, Tang ZY, Yu YQ, Wu ZQ, Ma ZC, Zhou XD, Zhou J, Qui SJ, Lu JZ. Improved survival with resection alter transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma. Dig Surg 1998; 15: 674-678
16. Sanz-Altamira PM, Spence LD, Huberman MS, Posner MR, Steele GJr, Perry LJ, Stuart KE. Selective chemoembolization in the management of hepatic metastasis in refractory colorectal carcinoma: a phase II trial. Dis Colon Rectum 1997; 40: 770-775
17. Okuda K, Peters RL, Simson IW. Gross Anatomic Features of Hepatocellular Carcinoma from three disparate Geographic Areas. Cancer 1984; 54: 2165-2173
18. Kanematsu T, Matsumata T, Shirabe K, Sugimachi K, Sakamoto S, Nawata H, Hasuo K, Honda H, Masuada K. A comparative study of hepatic resection and transcatheter arterial embolisation for the treatment of primary hepatocellular carcinoma. Cancer 1993; 68: 2150-2154
19. Nishimine K, Uchida H, Matsuo N, Sakaguchi H, Nishimura Y, Guo Q, Ohishi H, Nagano N, Yoshioka T, Ohue S, Fukui H, Tsujii T. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results. Cancer Chemother Pharmacol 1994; 33 (Suppl): S60-S68
20. Matsui O, Kadoya M, Yoshikawa J, Gabata T, Arai K, Demachi H, Miyayama S, Takashima T, Unoura M, Kogayashi K. Small Hepatocellular Carcinoma: Treatment with Subsegmental Transcatheter Arterial Embolization. Radiology 1993; 188: 79-83
21. Lopez RR Jr, Pan SH, Lois JF, McMonigle ME, Hoffman AL, Sher LS, Lugo D, Makowka L. Transarterial chemoembolization is a safe treatment for unresectable hepatic malignancies. Am Surg 1997; 63: 923-926
22. Yamashita Y, Takahashi M, Koga Y, Saito R, Nanakawa S, Hatanaka Y, Sato N, Nakashima K, Urata J, Yoshizumi K, Ito K, Sumi S, Kann M. Prognostic Factors in the Treatment of Hepatocellular Carcinoma With Transcatheter Arterial Embolization and Arterial Infusion. Cancer 1991; 67: 385-391
23. Ryder SD, Rizzi PM, Metivier E, Karani J, Wiliams R. Chemoembolisation with lipiodol and doxorubicin: applicability in British patients with hepatocellular carcinoma. Gut 1996; 38: 125-128
24. Buscarini L, Fomari F, Canaletti R, Sbolli G, Cavanna L, Di Stasi M. Diagnostic Aspect and Follow-Up of 174 Cases of Hepatocellular Carcinoma. Oncology 1991; 48: 26-30
25. Taniquchi K, Nakato K, Kato Y, Sato Y, Hamasaki K, Tsuruta S, Nakataki S. Treatment of hepatocellular carcinoma with transcatheter arterial embolisation. Analysis of prognostic factors. Cancer 1994; 73: 1341-1345
26. Yamamoto K, Masuzawa M, Kato M, Okuyama T, Tamura K. Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolisation. Cancer Chemother Pharmacol 1992; 31 (Suppl): S77-S81
27. Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer 1997; 79: 2087-2094
28. Kenji J, Hyodo I, Tnaimizo M, Nishikawa Y, Hosokawa Y, Mandai K, Moriwaki S. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial Infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases. Semin Oncol 1997; 24 (2 Suppl 6): S6-S71S680
29. Vogl TJ, Trapp M, Pegios W, Mack M, Bechsteon WO, Keck W, Scholz A, Schröder H, Neuhaus P, Felix R. Volumetrische und morphologische CT-Parameter zur Prognoseabschätzung und Therapiekontrolle des hepatozellularen Karzinoms unter arterieller Chemoembolisation. Fortschr. Röntgenstr 1997; 167: 219-226